Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...

Advanced Micro Devices stock (NASDAQ:AMD) increased by more than 4% during Tuesday's trading session and has risen by nearly ...

Advanced Micro Devices, Inc. continues to show strong growth, especially in AI and data center segments. Learn more about AMD ...

Advanced Micro Devices delivered first-quarter earnings that topped analysts’ estimates as sales from its data center segment ...

AMD recently released a set of Q1 results that surpassed expectations, and its outlook for Q2 was also more favorable than anticipated.

Advanced Micro Devices is scheduled to report first-quarter earnings after the bell on Tuesday, and traders are expecting a ...

Advanced Micro Devices has an undervalued stock and strong fundamentals, driven by growth catalysts and strategic moves.

Advanced Micro Devices' (AMD) stock whipsawed in early trading Wednesday morning as investors digested the company's better-than-anticipated Q1 earnings report and stronger-than-expected outlook ...

The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

Advanced Micro Devices stock (NASDAQ:AMD ... Q1 Earnings AMD’s Q1 results were also better than expected, with its outlook for Q2 also coming in ahead of estimates. Revenue rose by 36% ...

Advanced Micro Devices (NASDAQ: AMD) saw its stock climb over 5% in after-hours trading on Tuesday after reporting ...

Advanced Micro Devices (AMD) has been on a tear lately. Over the past month, the stock has surged about 32%, with a healthy 6 ...